Inactivated poliovirus – (IPV)
Recommended Age Range:
2, 4, 6–18 months, and 4–6 years
Common Side Effects:
Soreness at site, fussiness, drowsiness
Research & Testing History:
Introduced 1955; tested in 1.8 million children (Salk trial); replaced OPV in U.S. in 2000.
Use History:
In use since 1955
Trial Size:
1.8M+ in historic trials
Years on Schedule:
~70 years
Known Safety Concerns:
Rare allergic reactions
Ingredients:
Inactivated poliovirus types 1, 2, and 3, 2-phenoxyethanol, formaldehyde, neomycin, streptomycin, polymyxin B, aluminum hydroxide.
Learn More Here